Anna M Tsalenko

Title: Anna M Tsalenko: Innovator in Nucleotide Sequence Analysis

Introduction

Anna M Tsalenko is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of nucleotide sequence analysis, holding 2 patents that enhance the sensitivity and accuracy of nucleic acid analyses. Her work is crucial for advancing genetic research and diagnostics.

Latest Patents

Anna's latest patents include innovative methods and reagents for analyzing the nucleotide sequence of nucleic acids. One patent describes methods that provide more sensitive, accurate, and higher throughput analyses of target nucleic acid sequences. These methods do not require prior information about mutations in the target sequences, making them versatile for various applications. The reagents consist of oligonucleotide precursors with high coverage and mass number complexity, featuring tags that can be analyzed by mass spectrometry. Another patent focuses on analyzing nucleotide sequences using mass-modified oligonucleotide precursors, employing chemical or enzymatic assays to alter the mass of the precursors before mass spectral analysis.

Career Highlights

Anna M Tsalenko is currently associated with Agilent Technologies, Inc., where she continues to develop innovative solutions in the field of nucleic acid analysis. Her work has positioned her as a key figure in advancing methodologies that are essential for genetic research.

Collaborations

Anna has collaborated with notable professionals in her field, including Jeffrey Robert Sampson and Zohar H Yakhini. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Anna M Tsalenko's contributions to nucleotide sequence analysis through her patents and work at Agilent Technologies, Inc. highlight her role as an influential inventor in the field. Her innovative methods are paving the way for more effective genetic analysis techniques.